Handheld dynamometer
DeviceEvaluation of muscle strength
NCT Number: NCT02806089
Aim of this study is to determine in chronic kidney disease patients:
* the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C reactive protein and decrease in serum albumin) on voluntary muscle strength impairment * the relationship between voluntary muscle strength and muscle mass * the relationship between voluntary muscle strength and lean body mass * the correlation between voluntary muscle strength and physical activity
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
AIDER, Montpellier, France
Aim of this study is to determine in chronic kidney disease patients:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evaluation of muscle strength
Evaluation of muscle mass using plasma creatinine level
Evaluation of lean body mass
Evaluation of physical activity
Evaluation of C reactive protein and albumin
Time frame: 1 day
data will be measured in Newton.meter
Time frame: 1 day
data will be obtained from plasma creatinine level and will be expressed in milligram/kilogram/day)
Time frame: 1 day
data will be expressed in kilogram
Time frame: 1 day
the score represents the daily physical activity according to a validated scale
Time frame: 1 day
the parameter will be measured in milligram/liter
Time frame: 1 day
the parameter will be measured in gram/liter
University Hospital, Montpellier
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02803541
Behavior, Chronic Disease
Claryville, New York, United States
View Trial DetailsNCT01462097
Behavior, Chronic Disease
Baltimore, Maryland, United States
View Trial DetailsNCT02787161
Behavior, Chronic Disease
Belo Horizonte, Minas Gerais, Brazil
View Trial DetailsNCT02467894
Behavior, Cardiovascular Diseases
The Bronx, New York, United States
View Trial Details